Disruption of the GDP-mannose synthesis pathway in Streptomyces coelicolor results in antibiotic hyper-susceptible phenotypes

Microbiology
Robert HowlettM C M Smith

Abstract

Actinomycete bacteria use polyprenol phosphate mannose as a lipid linked sugar donor for extra-cytoplasmic glycosyl transferases that transfer mannose to cell envelope polymers, including glycoproteins and glycolipids. We showed recently that strains of Streptomyces coelicolor with mutations in the gene ppm1 encoding polyprenol phosphate mannose synthase were both resistant to phage φC31 and have greatly increased susceptibility to antibiotics that mostly act on cell wall biogenesis. Here we show that mutations in the genes encoding enzymes that act upstream of Ppm1 in the polyprenol phosphate mannose synthesis pathway can also confer phage resistance and antibiotic hyper-susceptibility. GDP-mannose is a substrate for Ppm1 and is synthesised by GDP-mannose pyrophosphorylase (GMP; ManC) which uses GTP and mannose-1-phosphate as substrates. Phosphomannomutase (PMM; ManB) converts mannose-6-phosphate to mannose-1-phosphate. S. coelicolor strains with knocked down GMP activity or with a mutation in sco3028 encoding PMM acquire phenotypes that resemble those of the ppm1- mutants i.e. φC31 resistant and susceptible to antibiotics. Differences in the phenotypes of the strains were observed, however. While the ppm1- strains have a smal...Continue Reading

References

Jul 18, 1997·The Journal of Biological Chemistry·G S BesraP J Brennan
Feb 17, 1999·Archives of Biochemistry and Biophysics·B Ning, A D Elbein
Jan 9, 2003·The Journal of Biological Chemistry·Stephen L MichellR Glyn Hewinson
Feb 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bertolt GustKeith F Chater
Jan 6, 2005·The Journal of Biological Chemistry·Hee-Jeon HongMark J Buttner
May 27, 2005·Nucleic Acids Research·Antonio Rodríguez-GarcíaMargaret C M Smith
Jan 21, 2006·Science·Vanessa M D'CostaGerard D Wright
May 15, 2009·The Journal of Biological Chemistry·Mario Sandoval-CalderónChristian Sohlenkamp
Dec 22, 2009·Applied Microbiology and Biotechnology·Yung-Hun YangByung-Gee Kim
Aug 31, 2010·The Journal of Biological Chemistry·Marcelo E GuerinMary Jackson
Mar 14, 2012·Molecular Microbiology·Vinod JyothikumarPaul R Herron
Oct 19, 2012·Journal of Microbiology and Biotechnology·Thangamani RajeshYung-Hun Yang
Apr 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Chia-Fang LiuMichel Rivière
Apr 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Weishan WangKeqian Yang
Jun 3, 2014·BMC Biotechnology·Bahgat FayedMargaret C M Smith

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
glycosylation
PCR
protein assay

Software Mentioned

SIGMAplot

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.